While weight loss drugs like Ozempic and Mounjaro are in an enduring shortage dating back to 2022, compounding pharmacies are allowed to sell their own versions. Though the practice is FDA-authorized, it is heatedly disputed by the brand-name companies, which cite “serious health risks.”
↧